Navigation Links
Watson Confirms Pataday™ Patent Challenge
Date:6/14/2011

watson.com/">http://www.watson.com.

Forward-Looking Statement Statements contained in this press release that refer to non-historical facts are forward-looking statements that reflect Watson's current perspective of existing information as of the date of this release. It is important to note that Watson's goals and expectations are not predictions of actual performance. Actual results may differ materially from Watson's current expectations depending upon a number of factors, risks and uncertainties affecting Watson's business. These factors include, among others, the difficulty of predicting the timing or outcome of product development efforts, including FDA and other regulatory agency approvals and actions, if any; the difficulty of predicting the timing and outcome of the pending patent litigation; the impact of competitive products and pricing; the timing and success of product launches; difficulties or delays in manufacturing; the availability and pricing of third party sourced products and materials; successful compliance with FDA and other governmental regulations applicable to Watson and its third party manufacturers' facilities, products and/or businesses; changes in the laws and regulations, including Medicare and Medicaid, affecting among other things, pricing and reimbursement of pharmaceutical products; and such other risks and uncertainties detailed in Watson's periodic public filings with the Securities and Exchange Commission, including but not limited to Watson's quarterly report on form 10-Q for the quarter ended March 31, 2011 and Watson's annual report on Form 10-K for the year ended December 31, 2010. Except as expressly required by law, Watson disclaims any intent or obligation to update these forward-looking statements.  

Pataday™ (olopatadine hydrochloride ophthalmic solution) 2% is a trademark of Novartis AG. CONTACTS:Investors:Patty Eisenhaur(862) 621-8141Media:Charlie Mayr(862) 621-8030(Logo: http://photos.
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Watson Launches Generic Biaxin(R) XL
2. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
3. Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
4. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
5. Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
6. Watson and Barr Settle Lawsuit Over Oxytrol(R)
7. Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2009 Earnings and 2010 Outlook
8. Watson Completes Acquisition of Eden Biodesign
9. Watson to Present at Credit Suisse Healthcare Conference
10. Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy
11. Watson Files FDA Application for Generic Rozerem(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... -- "Whether it,s our family, our friends, all of ... a single sentence, Dr. Anthony Coyle , senior ... Centers for Therapeutic Innovation (CTI), sums up what ... biopharmaceutical companies. CTI,s unique model allows ... and the National Institutes of Health (NIH) to bridge ...
(Date:3/26/2015)... , March 26, 2015 Over-the-counter ... average American consumer. However, a new survey of ... ailments from the common cold to diabetes, can ... The research, conducted by the Private Label Manufacturers ... over-the-counter healthcare products, including those essential for treatment ...
(Date:3/26/2015)... Research and Markets ( ... "Global Smart Wearable Healthcare Devices and Services ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The analysts forecast ... market to grow at a CAGR of 30.42% ... covers the present scenario and the growth prospects ...
Breaking Medicine Technology:Collaboration for Cures: Teaming Up to Advance Science and Save Lives 2Consumers can keep over-the-counter medicine affordable by using store brands 2Global Smart Wearable Healthcare Devices and Services Market 2015-2019 WITH Apple, At&T, Ee, Google, Samsung, Sprint, Telefonica & T-Mobile Dominating 2
(Date:3/26/2015)... (PRWEB) March 26, 2015 Dr. ... 32nd annual Dallas Rhinoplasty Symposium and has trained ... reiterated the importance of evidence based medicine (EBM), that ... from well conducted research. , "We often hear from ... rhinoplasty, and while we are certainly not trying to ...
(Date:3/26/2015)... March 26, 2015 Florida Hospital teamed up ... For Your Health campaign and live Dr. Oz event, which ... March 21st. More than a thousand people came out to ... living. , The world renowned cardiothoracic surgeon and Emmy ... Linda Hurtado and a panel of experts for the live ...
(Date:3/26/2015)... (PRWEB) March 26, 2015 Behavioral ... consulting firm, announced the release of BathroomMap® , ... to increase access to public restrooms for travelers, especially ... bathroom apps, BathroomMap does not facilitate a paid, social ... to identify and rate local establishments that have clean, ...
(Date:3/26/2015)... San Frencisco, CA (PRWEB) March 26, 2015 ... Implant Center are proud to announce expanded offerings for ... The San Francisco Dental Implant Center has long been ... efforts have expanded its offerings to meet the strong ... pride in our reputation as a top-rated dental implant ...
(Date:3/26/2015)... Mirada, CA (PRWEB) March 26, 2015 ... shooting guard Wesley Matthews is out for the season ... This injury occurred while the Trail Blazers were competing ... sports medicine specialist, Izzy Silva, M.D., who ... on Matthews' injury and whether it could be prevented. ...
Breaking Medicine News(10 mins):Health News:Dr. Rod Rohrich Explores Evidence Based Innovations and Safety at the 32nd Annual Dallas Rhinoplasty Symposium 2Health News:Florida Hospital Welcome Dr. Oz to Tampa and Invites the Community to Attend Educational Seminars Hosted by Florida Hospital Physicians 2Health News:Florida Hospital Welcome Dr. Oz to Tampa and Invites the Community to Attend Educational Seminars Hosted by Florida Hospital Physicians 3Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 2Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 3Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 2Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 3Health News:Sports Medicine Specialist Weighs In on Wesley Matthew’s Significant Tendon Injury; Can it be Prevented? 2Health News:Sports Medicine Specialist Weighs In on Wesley Matthew’s Significant Tendon Injury; Can it be Prevented? 3Health News:Sports Medicine Specialist Weighs In on Wesley Matthew’s Significant Tendon Injury; Can it be Prevented? 4
... a Saint Louis University researcher, investigators found that a new ... hepatitis C patients who have not responded to previous treatment. ... , offer a new option for hepatitis C patients, and ... make their condition difficult to treat. "This ...
... Receptor Mutation Test May Be Key To Identifying Patient ... Calif., June 16 Clarient, Inc. (Nasdaq: ... services resource for pathologists, oncologists, and the pharmaceutical industry, ... test that can help physicians select the proper therapy ...
... CAMBRIDGE, England and SAN FRANCISCO, California, June ... leader in infrastructure software for the enterprise, today announced,that ... its,information processing solutions to securely capture, route, store and ... clinicians will be,able to view all of their patients, ...
... ... Singapore Economic Development Board (EDB) set up endowment fund. , ... Singapore (PRWEB) June 16, 2009 -- Singapore,s ... plant. The new plant is GlaxoSmithKline,s (GSK) first primary vaccine manufacturing facility and its ...
... ... hypertension medications and the financial help available for those living with the disease. ... (Vocus) June 16, 2009 -- ... those with pulmonary hypertension . The page is a pulmonary hypertension-specific source of help ...
... of ISI Web of Knowledge To Advance Research4Life Partnership ... The Healthcare & Science business of Thomson Reuters today ... developing world with access to critical scientific research. Special ... include Current Contents Connect, Medline, EndNote Web, and ResearcherID, ...
Cached Medicine News:Health News:Good news for some hard-to-treat hepatitis C patients 2Health News:Clarient Launches New Gene Mutation Test to Help Select Therapy for Non-Small Cell Lung Cancer 2Health News:Clarient Launches New Gene Mutation Test to Help Select Therapy for Non-Small Cell Lung Cancer 3Health News:Clarient Launches New Gene Mutation Test to Help Select Therapy for Non-Small Cell Lung Cancer 4Health News:Greater Cincinnati Behavioral Health Services Standardizes on Autonomy's Meaning-Based Technologies 2Health News:Greater Cincinnati Behavioral Health Services Standardizes on Autonomy's Meaning-Based Technologies 3Health News:GlaxoSmithKline Opens $600million Vaccine Plant In Singapore 2Health News:GlaxoSmithKline Opens $600million Vaccine Plant In Singapore 3Health News:New Source of Information on Pulmonary Hypertension Medications 2Health News:Thomson Reuters Partners with Research4Life to Bring Scientific Research Information Resources to Developing Countries Around the World 2Health News:Thomson Reuters Partners with Research4Life to Bring Scientific Research Information Resources to Developing Countries Around the World 3
The Budde Halo Retractor Side Rail Support is designed for the adaptation and attachment of the Budde Halo Brain Retractor System to the operating room table when a conventional skull clamp is not us...
Cone Ring Curettes, length 9" (229 mm), ring diameter (I.D.) 5/16" (8 mm)....
Scoville Ruptured Disc Curettes, length 10" (254 mm), cup size 4 x 10 mm....
PG Magnum Cup Curettes with large capacity cup sizes, total length 12.6" (32 cm) handle length 7.8" (20 cm), handle diameter 1.12" (3 cm), working distance 4.7" (12 cm)....
Medicine Products: